Genetic Variation in the Androgen Receptor Modifies the Association Between Testosterone and Vitality in Middle-Aged Men.
Level 4 - case-series / case-control
Cross-sectional observational study analyzing genetic moderation of hormone-symptom associations.
PubMed 33011098 · doi:10.1016/j.jsxm.2020.08.016
What was done
The authors investigated whether the relationship between circulating testosterone and vitality is moderated by the CAG repeat length in the androgen receptor (AR) gene. They analyzed 676 middle-aged male twins (mean age 55.4 ± 2.5 years) from the Vietnam Era Twin Study of Aging. Salivary testosterone was measured across 3 waking samples on nonconsecutive days and categorized as low, normal, or high using 1-SD cutoffs. Vitality was assessed using the SF-36 vitality subscale. Multilevel mixed linear models controlled for twin clustering, age, ethnicity, BMI, chronic conditions, depressive symptoms, and sleep quality.
What was found
A significant interaction was observed between salivary testosterone and AR-CAG repeat length. In men with shorter repeat lengths, low testosterone was significantly associated with lower vitality. As the repeat length increased, the magnitude of the testosterone effect on vitality decreased. The abstract did not report exact numerical effect sizes, test statistics, or p-values.
Why it matters
Genetic differences in androgen receptor sensitivity may explain why men experience variable vitality symptoms at similar testosterone levels and why testosterone replacement trials show heterogeneous results.
Limits
The analysis is cross-sectional, preventing causal or longitudinal conclusions. The cohort was ethnically homogeneous, limiting generalizability. Vitality was evaluated using a brief self-report subscale rather than objective functional measures.
Cited by
- supports Longer androgen receptor CAG repeat lengths are associated with decreased androgen receptor sensitivity to testosterone, requiring higher testosterone levels for the same effect.